> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pharmacy Plus Warning on Unapproved Covid Products
- URL: https://www.fdaweb.com/pharmacy-plus-warning-on-unapproved-covid-products/
- Published: 2020-09-11T12:00:00.000Z
- Updated: 2026-09-14T16:28:28.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147635

FDA has sent Pharmacy Plus (dba Vital Care Compounder) a [Warning Letter](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmacy-plus-inc-dba-vital-care-compounder-610477-09092020?ref=fdaweb.com) for offering unapproved drug products — Covid Pack and Covid Positive Pack — for prophylaxis, treatment and recovery from the Covid-19 virus. The letter takes issue with statements made on the company’s Web site touting the products, such as: “This supplement pack contains a 14-day supply of four physician recommended supplements...” Another statement FDA cited said the company’s supplements are “routinely prescribed for Covid-positive patients. Ideal to keep in the home for emergency use when a family member tests positive for the virus.” FDA told the company to correct the violations cited in the letter.